Randy Burd, Ph.D. is the Director of Research at BerylStone and an Associate Professor at University of Arizona. Randy received his Ph.D. in Molecular and Cellular Biophysics in 1998 from the Roswell Park Cancer Institute in Buffalo, New York and has worked in the area of pharmaceutical and biotechnology research for over a decade. In 2002 he was appointed the director of Pre-Clinical Therapeutics at Thomas Jefferson University. In 2005 he was recruited to the University of Arizona. Randy joined BerylStone in 2011 and currently co-manages BerylStone Investment's Managed Portfolios.